Archive: 17/03/2017
Evolocumab significantly reduces risk of cardiovascular events
Evolocumab, one of the new targeted PCSK9 inhibitor drugs that has been shown to dramatically lower levels of low-density lipoprotein (LDL), or "bad" cholesterol, also significantly lowers the risk of cardiovascular events ...
Mar 17, 2017
Self-expanding TAVR as good as surgery in intermediate-risk patients
Two-year data reveal no difference in the combined rate of stroke and death from any cause when comparing the use of self-expanding transcatheter aortic valve replacement (TAVR) with standard open-heart surgery in intermediate ...
Mar 17, 2017
PCSK9 inhibition with bococizumab yields mixed results
In a clinical program that was terminated early, the experimental PCSK9 inhibitor bococizumab, when given on top of effective statin therapy, had widely varying effects on LDL cholesterol levels and had no benefit on cardiovascular ...
Mar 17, 2017
Measles cases triple in Italy as parents shun vaccine
The number of measles cases in Italy has tripled this year, largely because parents are not getting children vaccinated due to spurious health scares, the health ministry said Friday.
Mar 17, 2017
Sexual assault victimization disproportionately affects certain minority college students
Students who perceive that their college campus is more inclusive and welcoming of sexual- and gender-minority people have lower odds of being victims of sexual assault, according to a study led by the University of Pittsburgh ...
Mar 17, 2017